CaaMTech is a pharmaceutical drug discovery company utilizing a collaborative scientific approach to engineering novel small-molecule therapeutics. We are focused on creating and optimizing next-generation psychedelic-inspired medicines to treat mental health conditions. CaaMTech has carefully selected a diverse group of highly-skilled experts including scientists, healthcare professionals, and technologists at the forefront of their respective fields. Our team members have Ph.D., MBA, and JD degrees from top US and international universities including Princeton, Harvard, and Cornell. CaaMTech’s combined experience connects multiple industries, including branded and generic pharmaceutical companies, natural product innovation, Silicon Valley startups, intellectual property law, consumer product development, manufacturing, and distribution.
| Website | https://caam.tech |
| Employees | 8 (4 on RocketReach) |
| Founded | 2019 |
| Industry | Pharmaceutical Manufacturing, Drug Discovery, Other Pharmaceuticals and Biotechnology |
| Keywords | Mental Health Treatment, Psychedelic Medicine, Psychedelic Therapeutics, Drug Discovery, Pharmaceutical Research, Small Molecule Therapeutics, Novel Therapeutics, Next Generation Medicine, Therapeutic Development, Drug Development, Biopharmaceutical, Clinical Trials, Pharmaceutical Innovation, Medicinal Chemistry, Drug Design, Preclinical Research, Biotechnology, Life Sciences, Pharmaceutical Technology, Healthcare |
| Competitors | Thermo Fisher Scientific, AstraZeneca, Boehringer Ingelheim, Agilent Technologies, Illumina, Wiley, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Molecular Devices +34 more (view full list) |
Looking for a particular CaaMTech employee's phone or email?
Davis Wuolle is the CTO of CaaMTech.
4 people are employed at CaaMTech.
CaaMTech is based in Issaquah, Washington.